| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |